These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8748574)

  • 1. Parkinsonian rigidity, dopa-induced dyskinesia and chorea--dynamic studies on the basal ganglia-thalamocortical motor circuit using PET scan and depth microrecording.
    Hirato M; Ishihara J; Horikoshi S; Shibazaki T; Ohye C
    Acta Neurochir Suppl; 1995; 64():5-8. PubMed ID: 8748574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
    Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S
    Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
    Hirato M; Horikoshi S; Kawashima Y; Satake K; Shibazaki T; Ohye C
    Adv Neurol; 1993; 60():511-4. PubMed ID: 8420180
    [No Abstract]   [Full Text] [Related]  

  • 4. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease.
    Guridi J; Obeso JA; Rodriguez-Oroz MC; Lozano AA; Manrique M
    Neurosurgery; 2008 Feb; 62(2):311-23; discussion 323-5. PubMed ID: 18382309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered thalamic response to levodopa in Parkinson's patients with dopa-induced dyskinesias.
    Hershey T; Black KJ; Stambuk MK; Carl JL; McGee-Minnich LA; Perlmutter JS
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):12016-21. PubMed ID: 9751782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the function of the basal ganglia and frontal cortex using depth microrecording and PET scan in relation to the outcome of pallidotomy for the treatment of rigid-akinesia-type Parkinson's disease.
    Hirato M; Ohye C; Takahashi A; Negishi M; Shibasaki T
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):86-92. PubMed ID: 9711739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Cortico-Basal Ganglia Neurotransmission in a Mouse Model of l-DOPA-Induced Dyskinesia.
    Dwi Wahyu I; Chiken S; Hasegawa T; Sano H; Nambu A
    J Neurosci; 2021 Mar; 41(12):2668-2683. PubMed ID: 33563724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic surgery and Parkinson's disease.
    Narabayashi H
    Stereotact Funct Neurosurg; 1998; 70(2-4):114-21. PubMed ID: 9780407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
    Li XY; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of selective thalamotomy for various kinds of movement disorder, based on basic studies.
    Ohye C
    Stereotact Funct Neurosurg; 2000; 75(2-3):54-65. PubMed ID: 11740171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of motor fluctuations in Parkinson's disease.
    Widnell K
    Mov Disord; 2005; 20 Suppl 11():S17-22. PubMed ID: 15822108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Task specific influences of Parkinson's disease on the striato-thalamo-cortical and cerebello-thalamo-cortical motor circuitries.
    Lewis MM; Slagle CG; Smith AB; Truong Y; Bai P; McKeown MJ; Mailman RB; Belger A; Huang X
    Neuroscience; 2007 Jun; 147(1):224-35. PubMed ID: 17499933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic correlates of levodopa response in Parkinson's disease.
    Feigin A; Fukuda M; Dhawan V; Przedborski S; Jackson-Lewis V; Mentis MJ; Moeller JR; Eidelberg D
    Neurology; 2001 Dec; 57(11):2083-8. PubMed ID: 11739830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection criteria for unilateral posteroventral pallidotomy.
    Alterman RL; Kelly P; Sterio D; Fazzini E; Eidelberg D; Perrine K; Beric A
    Acta Neurochir Suppl; 1997; 68():18-23. PubMed ID: 9233408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.
    Bergman H; Wichmann T; Karmon B; DeLong MR
    J Neurophysiol; 1994 Aug; 72(2):507-20. PubMed ID: 7983515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of depotentiation at basal ganglia output neurons in PD patients with levodopa-induced dyskinesia.
    Prescott IA; Liu LD; Dostrovsky JO; Hodaie M; Lozano AM; Hutchison WD
    Neurobiol Dis; 2014 Nov; 71():24-33. PubMed ID: 25116960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model.
    Ando K; Inoue T; Itoh T
    Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of parkinsonian motor abnormalities.
    Wichmann T; DeLong MR
    Adv Neurol; 1993; 60():53-61. PubMed ID: 8420185
    [No Abstract]   [Full Text] [Related]  

  • 19. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
    Krack P; Pollak P; Limousin P; Benazzouz A; Deuschl G; Benabid AL
    Brain; 1999 Jun; 122 ( Pt 6)():1133-46. PubMed ID: 10356065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiparkinsonian and anti-levodopa-induced dyskinesia effects obtained by stimulating the same site within the GPi in PD.
    Stanzione P; Mazzone P; Peppe A; Pierantozzi M; Stefani A; Bassi A; Bernardi G
    Neurology; 1998 Dec; 51(6):1776-7. PubMed ID: 9855559
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.